Get the Stockscreener App
16.03
2.02%
-0.33
Freenome, Inc. Common stock stock is traded at $16.03, with a volume of 648.25K.
It is down -2.02% in the last 24 hours and up +0.25% over the past month.
See More
Previous Close:
$16.36
Open:
$16.2
24h Volume:
648.25K
Relative Volume:
1.13
Market Cap:
$1.72B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+2.49%
1M Performance:
+0.25%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$15.48
$17.30
52-Week Range:
$9.97
$17.50
Freenome, Inc. Common stock Stock (FRNM) Company Profile
Name
Freenome, Inc. Common stock
Sector
Industry
Phone
-
Address
-
Compare FRNM vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FRNM
Freenome, Inc. Common stock
|
16.03 | 1.72B | 0 | 0 | 0 | 0.00 |
TMO
Thermo Fisher Scientific Inc
|
638.83 | 236.21B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
213.14 | 149.83B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
386.36 | 55.69B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
164.35 | 46.34B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
252.95 | 41.64B | 16.63B | 1.39B | 2.12B | 8.0674 |
Freenome, Inc. Common stock Stock (FRNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-26 | Initiated | Guggenheim | Buy |
| Aug-18-26 | Initiated | TD Cowen | Buy |
| Aug-17-26 | Initiated | BTIG Research | Buy |
| Aug-17-26 | Initiated | Jefferies | Buy |
| Aug-14-26 | Initiated | Leerink Partners | Outperform |
Freenome, Inc. Common stock Stock (FRNM) Latest News
IPO Calendar for: - Yahoo! Finance Canada
Freenome, Inc. Common stock (NASDAQ: FRNM) Share Price, FRNM Stock News, FRNM Share Price & Updates - kalkine.ca
Freenome, Inc. Common stock (NASDAQ: FRNM) Share Price, FRNM Stock News, FRNM Share Price & Updates - kalkine.com.au
Roche group holds 18.7M Freenome (NASDAQ: FRNM) shares - Stock Titan
Freenome Registers Up To 75.2 Million Shares For Sale - Yahoo Finance
Freenome, Inc. (FRNM) insider converts 30,000 Class B shares - Stock Titan
Freenome, Inc. (PCSC) director reports common stock and option stakes - Stock Titan
Freenome, Inc. (FRNM) director Douglas Van Oort details equity stake - Stock Titan
Freenome, Inc. (FRNM) CEO details stock and option positions - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Freenome, Inc. Common stock (FRNM) Historical Quotes - Nasdaq
Wilson Sonsini Advises Freenome on IP Matters Related to Business Combination, Public Company Launch - Wilson Sonsini
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Freenome (FRNM) Stock Price, News & Analysis - Stock Titan
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection - globenewswire.com
Cancer detection specialist Freenome lists on Nasdaq through special purpose merger - mugglehead.com
Freenome to go public via PCSC SPAC (PCSC): $240M PIPE, $525M pro forma cash - Stock Titan
Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform - PR Newswire
PCSC SEC FilingsPerceptive Capital Solutions Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Perceptive Capital Solutions (PCSC) Stock Price, News & Analysis - Stock Titan
AXGN Stock Price and Chart — NASDAQ:AXGN - TradingView
Freenome, Inc. Common stock Stock (FRNM) Financials Data
There is no financial data for Freenome, Inc. Common stock (FRNM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.44%
3.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):